Interferon and retinoic acid in human cancer: Clinical and mechanistic studies;L'interferon et l'acide retinoique dans le traitement des cancers humains: Mecanismes d'action

Bulletin du Cancer

Volumn 85, Issue 4, 1998, Pages 313-318

  Pelicano, Luis ^a   Chelbi Alix, Mounira K ^a  

^a CNRS   (France)

Author keywords

Interferon; IRF1; p48; Retinoic acid; Stat1

Indexed keywords

INTERFERON; RETINOIC ACID; ALPHA INTERFERON; ANTINEOPLASTIC AGENT; BETA INTERFERON; TRANSACTIVATOR PROTEIN;

ANTINEOPLASTIC ACTIVITY; CANCER; CELL PROLIFERATION; DRUG POTENTIATION; HUMAN; REVIEW; SIGNAL TRANSDUCTION; CLASSIFICATION; DRUG INTERACTION; METABOLISM; PHOSPHORYLATION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DRUG INTERACTIONS; HUMANS; INTERFERON-ALPHA; INTERFERON-BETA; INTERFERONS; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; TRETINOIN;

EID: 0032042910     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Isaacs A, Lindenmann J. Virus interference. I. The interferon. Proc Roy Soc London B 1957 ; 147 : 258-67.
2. Sen GC, Ransohoff RM. Interferon-induced antiviral actions and their regulation. Adv Virus Res 1993 ; 42 : 57-102.
3. Billard C. Les interférons, une classe de cytokines ayant un large spectre d'activité thérapeutique. Bull Cancer 1993 ; 80 : 741-56.
4. Gresser I. Wherefore interferon ? J Leukoc Biol 1997 ; 61 : 567-74.
5. Einhorn S, Grander D. Why do so many cancer patients fail to respond to interferon therapy ? J Interferon Cytokine Res 1996 ; 16: 275-81.
6. Lindner DJ, Kalvakolanu DV, Borden EC. Increasing effectiveness of interferon-alpha for malignancies. Semin Oncol 1997 ; 24, S9-104.
7. Hall GL, Compston A, Scolding NJ. Beta-interferon and multiple sclerosis. Trends Neurosci 1997 ; 20 : 63-7.
8. Fradelizi D. Les cytokines ont 20 ans : de la culture cellulaire aux applications thérapeutiques, médecineJsciences 1996 ; 12 : 44-7.
9. Warrell RJr, de Thé H, Wang ZY, Degos L. Acute promyelocytic leukemia. N Engl J Med 1993 ; 329 : 177-89.
10. Zhu J, Koken MHM, Quignon F, Chelbi-Alix MK, Degos L, Wang ZJ, et al. Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia. Proc Natl Acad Sci USA 1997 ; 94 : 3978-83.
11. Yoshida H, Kitamura K, Tanaka K, Omura S, Miyazaki T, Hachiya T, at al. Accelerated degradation of PML-retinoic acid receptor alpha (PMLRARA) oncoprotein by all-trans-retinoic acid in acute promyelocytic leukemia. Possible role of the proteasome pathway. Cancer Res 1996; 56: 2945-8.
12. Chelbi-Alix MK, Pelicano L, Quignon F, Koken MHM, Venturini L, Stadier M, et al. Induction of the PML protein by interferons in normal and APL cells. Leukemia 1995 ; 9 : 2027-33.
13. Warrell R Retinoid resistance. Lancet 1993 ; 341 : 126.
14. Eisenhauer EA, Lippman SM, Kavanagh JJ, Parades-Espinoza M, Arnold A, Hong WK, et al. Combination 13-cis-retinoic acid and interferon alpha-2α in the therapy of solid tumors. Leukemia 1994 ; 8 : 1622-5.
15. Lippman SM, Lotan R, Schleuniger U. Retinoid-interferon therapy of solid tumors. Int J Cancer 1997 ; 70 : 481-3.
16. Diaz MO, Bohlander S, Allen G. Nomenclature of the human Interferon genes. J Interferon Cytokine Res 1996 ; 16 : 179-80.
17. Allen G, Diaz MO. Nomenclature of the human Interferon proteins. J Interferon Cytokine Res 1996 ; 16 : 181-4.
18. Chelbi-Alix MK, Brouard A, Boissard C, Pelaprat D, Rostene W, Thang MN. Induction by vasoactive intestinal peptide of interfcron synthesis in glial cells but not in neurons. J Cell Physiol 1994 ; 158 : 47-54.
19. Pelicano L, Li F, Schindler C, Chelbi-Alix MK. Retinoic acid enhances the expression of interferon-induced proteins : evidence for multiple mechanisms of action. Oncogene 1997 ; 15: 2349-59.
20. Darncll J The Jak-Stat pathway : summary of initial studies and recent advances. Recent Prog Harm Res 1996 ; 51 : 391-404.
21. Decker T, Kovarik P, Meinke A. GAS elements: a few nucleotides with a major impact on cytokine-induced gene expression. J Interferon Cytokine Res 1997 ; 17 : 121-34.
22. Koken MHM, Linares-Cruz G, Quignon F, Viron A, Chelbi-Alix MK, Sobczak-Thépot J, et al. The PML growth-suppressor has an altered expression in human oncogenesis. Oncogene 1995 ; 10 : 1315-24.
23. Chelbi-Alix MK, Quignon F, Pelicano L, Koken MHM, de Thé H. Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein.J Virol 1998 ; 72: 1043-510.
24. Napoli JL. Biochemical pathways of retinoid transport, metabolism, and signal transduction. Clin hmnunol Immunopathol 1996 ; 80 : S52-62.
25. Minucci S, Ozato K. Retinoid receptors in transcriptional regulation. Curr Opin Genet Dev 1996 ; 6 : 567-74.
26. Grant S, Bhalla K, Weinslein B, Pestka S, Mileno MD, Fisher PB. Recombinant human Interferon sensitizes resistant myeloid leukemic cells to induction of terminal differentiation. Biocbem Biophys Res Commun 1985; 130:379-88.
27. Hemmi H, Breitman TR. Combinations of recombinant human interferons and retinoic acid synergistically induce differentiation of the human promyelocytic leukemia cell line HL-60. Blood1987 ; 69 : 501-7.
28. Peck R, Bollag W. Potentiation of retinoid-induced differentiation of HL-60 and U937 cell lines by cytokines. EUT J Cancer 1991 ; 27 : 53-7.
29. Higuchi T, Hannigan GE, Malkin D, Yeger H, Williams BR. Enhancement by retinoic acid and dibutyryl cyclic adenosine 3':5'- monophosphate of the differentiation and gene expression of human neuroblastoma cells induced by interferon. Cancer Res 1991 ; 51 : 3958-64.
30. Lancillotti F, Giandomenico V, Affabris E, Fiorucci G, Romeo G, Rossi GB. Interferon alpha-2b and retinoic acid combined treatment affects proliferation and gene expression of human cervical carcinoma cells. Cancer Res 1995 ; 55 : 3158-64.
31. Matikainen S, Ronni T, Hurme M, Pine R, Julkunen I. Retinoic acid activates interferon regulatory factor-1 gene expression in myeloid cells. Blood 1996;88: 114-23.
32. Pine R, Canova A, Schindlet C. Tyrosine phosphorylated p91 binds to a single element in the ISGF2JIRF1 promoter to mediate induction by IFN alpha and IFN gamma, and is likely to autoregulate the p91 gene. EMBO J 1994 ; 13 : 158-67.
33. Gianni M, Terao M, Fortino I, LiCalzi M, Viggiano V, Barbui T, et al. Stall is induced and activated by all-trans retinoic acid in acute promyelocytic leukemia cells. Blood 1997 ; 3 : 1001-12.
34. Matikainen S, Ronni T, Lehtonen A, Sareneva T, Melen K, NordlingS, et al. Retinoic acid induces signal transducer and activator of transcription (Stat)l, Stat2, and p48 expression in myeloid leukemia cells and enhances their responsiveness to interferons. Cell Growth Differ 1997 ; 8: 687-98.
35. Kolla V, Lindner DJ, Weihua X, Borden EC, Kalvakolanu DV. Modulation of interferon (IFN)-inducible gene expression by retinoic acid. Up-regulation of Statl protein in IFN-unresponsive cells. J Biol Chem 1996:271 : 10508-14.
36. Weihua X, Kolla V, Kalvakolanu DV. Modulation of interferon action by retinoids. Induction of murine Statl gene expression by retinoic acid. J Biol Chem 1997 ; 272 : 9742-8.